These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 16262874

  • 1. Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases.
    Nawrot U, Nowicka J, Juszczak K, Gusin B.
    Mycoses; 2005 Nov; 48(6):385-90. PubMed ID: 16262874
    [Abstract] [Full Text] [Related]

  • 2. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents.
    Citak S, Ozçelik B, Cesur S, Abbasoğlu U.
    Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993
    [Abstract] [Full Text] [Related]

  • 3. Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.
    Gualco L, Debbia EA, Bandettini R, Pescetto L, Cavallero A, Ossi MC, Schito AM, Marchese A.
    Int J Antimicrob Agents; 2007 Feb; 29(2):179-84. PubMed ID: 17175140
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M, Kunz L, Rüchel R, Reichard U, Weig M, Gross U.
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [Abstract] [Full Text] [Related]

  • 5. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA.
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [Abstract] [Full Text] [Related]

  • 6. [Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
    Alvarado D, Díaz MC, Silva V.
    Rev Med Chil; 2002 Apr; 130(4):416-23. PubMed ID: 12090107
    [Abstract] [Full Text] [Related]

  • 7. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003.
    da Matta DA, de Almeida LP, Machado AM, Azevedo AC, Kusano EJ, Travassos NF, Salomão R, Colombo AL.
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):399-404. PubMed ID: 17240110
    [Abstract] [Full Text] [Related]

  • 8. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V, Barnes AJ.
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [Abstract] [Full Text] [Related]

  • 9. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A, Sancak B, Arikan S.
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [Abstract] [Full Text] [Related]

  • 10. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
    Gültekin B, Eyigör M, Tiryaki Y, Kırdar S, Aydın N.
    Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
    [Abstract] [Full Text] [Related]

  • 11. [Susceptibility to miconazole and itraconazole of Candida strains isolated from hospitalized and outpatient clinic patients].
    Kurnatowska AK, Kwaśniewska J.
    Wiad Parazytol; 2009 Apr; 55(4):415-23. PubMed ID: 20209818
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals.
    Zaoutis TE, Foraker E, McGowan KL, Mortensen J, Campos J, Walsh TJ, Klein JD.
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):295-8. PubMed ID: 15922535
    [Abstract] [Full Text] [Related]

  • 16. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA.
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [Abstract] [Full Text] [Related]

  • 17. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.
    Samonis G, Kofteridis DP, Saloustros E, Giannopoulou KP, Ntziora F, Christidou A, Maraki S, Falagas ME.
    Scand J Infect Dis; 2008 Feb; 40(5):414-9. PubMed ID: 18418802
    [Abstract] [Full Text] [Related]

  • 18. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM, Weikert-Oliveira Rde C, Lyon JP, Cury VF, Arantes RR, Koga-Ito CY, Resende MA.
    Microbiol Res; 2008 Feb; 163(5):579-85. PubMed ID: 16962755
    [Abstract] [Full Text] [Related]

  • 19. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
    Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, Lee JS, Jung SI, Park KH, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW.
    Clin Infect Dis; 2009 Mar 15; 48(6):e57-61. PubMed ID: 19193113
    [Abstract] [Full Text] [Related]

  • 20. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L.
    Rev Argent Microbiol; 2001 Mar 15; 33(4):217-22. PubMed ID: 11833253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.